Ophthalmologic Baseline Characteristics and 2-Year Ophthalmologic Safety Profile of Pramipexole IR Compared with Ropinirole IR in Patients with Early Parkinson’s Disease

Background. Parkinson’s disease (PD) progressively affects dopaminergic neurotransmission and may affect retinal dopaminergic functions and structures. Objective. This 2-year randomized, open-label, parallel-group, flexible-dose study, NCT00144300, evaluated ophthalmologic safety profiles of immedia...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	William Seiple, Danna Jennings, Richard B. Rosen, Leona Borchert, Lee Canale, Nora Fagan, Mark Forrest Gordon
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Wiley 2016-01-01
Seri Bilgileri:	Parkinson's Disease
Online Erişim:	http://dx.doi.org/10.1155/2016/8298503
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!